Wellington Management Group’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25M | Buy |
1,433,187
+1,301,411
| +988% | +$22.7M | ﹤0.01% | 888 |
|
|
2025
Q1 | $1.66M | Sell |
131,776
-31,476
| -19% | -$396K | ﹤0.01% | 1595 |
|
|
2024
Q4 | $1.72M | Buy |
163,252
+917
| +0.6% | +$9.67K | ﹤0.01% | 1594 |
|
|
2024
Q3 | $2.35M | Buy |
162,335
+45,452
| +39% | +$659K | ﹤0.01% | 1500 |
|
|
2024
Q2 | $995K | Buy |
116,883
+3,678
| +3% | +$31.3K | ﹤0.01% | 1670 |
|
|
2024
Q1 | $1.16M | Buy |
+113,205
| New | +$1.16M | ﹤0.01% | 1652 |
|
|
2021
Q1 | – | Sell |
-13,837
| Closed | -$641K | – | 2178 |
|
|
2020
Q4 | $641K | Buy |
+13,837
| New | +$641K | ﹤0.01% | 1678 |
|